Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

Abstract Circulating antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload in heart failure. This study aimed to evaluate the effect of dapagliflozin on short-term CA125 levels in patients with stable heart failure with reduced ejection fraction (HFrEF) and whether these changes...

Full description

Bibliographic Details
Main Authors: Martina Amiguet, Patricia Palau, Eloy Domínguez, Julia Seller, Jose Manuel Garcia Pinilla, Rafael de la Espriella, Gema Miñana, Alfonso Valle, Juan Sanchis, Jose Luis Górriz, Antoni Bayés-Genís, DAPA VO2 investigators, Julio Núñez
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-37491-5

Internet

https://doi.org/10.1038/s41598-023-37491-5

Similar Items